Welcome to Visited Lingnan Modern Clinics In Surgery, Today is Share:
High cost and frequent adverse events： the future of Cabozantinib for the first-line treatment of metastatic renal cell carcinoma
YANG Jing-ying, XIE Ying-wei, ZHU Ding-jun, XIE Wen-lian
Lingnan Modern Clinics In Surgery . 2021, (04): 387 -391 .  DOI: 10.3969/j.issn.1009-976X.2021.04.003

粤ICP备17161812号
Copyright © Lingnan Modern Clinics In Surgery, All Rights Reserved.
Tel: 020-34071463　E-mail: lingnanwaike@126.com
Powered by Beijing Magtech Co., Ltd.